Brief: Oncosec Presents Pre-Clinical Data From Visceral Lesion Applicator & Apollo Feasibility Study
21/04/2020 14:19
April 21 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC PRESENTS PRE-CLINICAL DATA FROM VISCERAL LESION
APPLICATOR & APOLLO FEASIBILITY STUDY DEMONSTRATING TAVO CAN BE
SAFELY DELIVERED & ELECTROPORATED IN LIVER
Source text for Eikon: ID:nPn5R6z47a
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq